News
Alopecia areata, an autoimmune disorder causing hair loss, now has an FDA-approved treatment since June 2022. While some ...
Alopecia areata, an autoimmune condition, leads to patchy hair loss due to immune system attacks on hair follicles. Garlic, with its allicin and sulfu ...
Discover 6 shocking truths about sudden hair loss and alopecia areata. Learn life-changing strategies that restore confidence and promote regrowth.
Sun Pharmaceutical Industries, announced its release of Leqselvi in the U.S. earlier this week. Leqselvi™ is currently ...
Leqselvi (deuruxolitinib) 8 mg tablets are approved for adults with severe alopecia areata, a disease that causes the immune ...
"The launch of LEQSELVI in the U.S. brings an effective, new treatment option for severe alopecia areata to eligible patients and the healthcare providers who treat them," said Richard Ascroft, CEO, ...
A new study offers insights into the relative efficacy of various treatments for alopecia areata (AA), suggesting that deuruxolitinib (Leqselvi; Sun Pharma) at a dosage of 12 mg twice daily for 24 ...
Sun Pharmaceutical Industries Limited announced Leqselvi (deuruxolitinib) 8 mg tablets is now available to healthcare providers and people living with severe alopecia areata in the US. Leqselvi is ...
Mumbai: Sun Pharmaceutical Industries Limited has announced the launch of LEQSELVI (deuruxolitinib) 8 mg tablets in the U.S.
The stigma of having alopecia causes more depression and anxiety than the disease itself, new research has found.
LEQSELVI has been approved by the US FDA, following strong results from clinical trials and is now available to adults ...
AA is linked to increased anxiety and depression, especially in females and younger patients, with variations across countries. The study found significant associations between AA and mental health in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results